SFPIA
ARRY

Stevens First Principles Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,000
Closed -$12K – 233
2013
Q3 		$12K Sell
2,000
-1,500
-43% -$8.91K 0.01% 174
2013
Q2 		$16K Buy
+3,500
New +$18.8K 0.01% 170

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stevens First Principles Investment Advisors's ARRY Position: Q4 2013 in Review

Stevens First Principles Investment Advisors sold out of Array Biopharma Inc (ARRY) in Q4 2013, closing a stake of 2,000 shares — an estimated $12K sold.

Stevens First Principles Investment Advisors first reported a position in ARRY in Q2 2013 and held it in 2 quarters. The position peaked at $16K in Q2 2013. 143 funds tracked by Wall St. Rank hold ARRY as of Q4 2013.

  • Stevens First Principles Investment Advisors reported no remaining Array Biopharma Inc position as of Q4 2013 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 2,000 Array Biopharma Inc shares in Q4 2013, an estimated $12K.
  • Stevens First Principles Investment Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 2 quarters.
  • Stevens First Principles Investment Advisors's Array Biopharma Inc position peaked at $16K in Q2 2013.
  • 143 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2013.

Based on Stevens First Principles Investment Advisors's 13F filing for Q4 2013, filed 7 Feb 2014.